Labetalol and extended-release nifedipine are the two blood pressure medications most widely considered safe during pregnancy. Both are recommended as first-line treatments by the American College of Obstetricians and Gynecologists (ACOG), which advises starting medication when blood pressure reaches 140/90 mm Hg or higher in pregnant patients with chronic hypertension. The choice between them often depends on how your body responds and whether you have other health conditions like asthma or diabetes.
Labetalol: The Most Common First Choice
Labetalol works by blocking two types of signals that raise blood pressure: one that tightens blood vessels and another that speeds up the heart. This dual action makes it effective at lowering blood pressure without causing the sharp drops that can reduce blood flow to the placenta. It’s typically started at 100 mg twice daily, with the dose gradually increased based on your response. Most people end up on 200 to 400 mg twice daily for maintenance, though severe cases can require up to 2,400 mg per day.
Labetalol is also one of the safest options if you plan to breastfeed. Studies estimate that a nursing infant receives only 0.004% to 0.07% of the mother’s weight-adjusted dose through breast milk, which is far below the 5% to 10% threshold considered safe. The main reason some women can’t take it is asthma, since it can tighten airways. In that case, nifedipine is the usual alternative.
Nifedipine: The Primary Alternative
Extended-release nifedipine belongs to a class of drugs called calcium channel blockers. It relaxes the muscles in blood vessel walls, allowing them to widen and reducing the pressure your heart has to pump against. It’s particularly useful for women who can’t tolerate labetalol or who have asthma.
The safety data on nifedipine is slightly more mixed than for labetalol. Some studies found a small increase in birth defect risk with first-trimester exposure, while others did not. Two studies reported higher rates of preterm delivery (before 37 weeks) and lower birth weight in women taking calcium channel blockers. On the reassuring side, follow-up studies of children exposed to nifedipine in the womb found no concerns about behavior or learning problems. Nifedipine also passes into breast milk in very small amounts. Infants receive roughly 0.1% of their mother’s weight-adjusted dose, well within the safe range.
Methyldopa: A Older Option Still in Use
Methyldopa has been used in pregnancy since the 1960s and has no known ability to cause birth defects. It works by acting on the brain to reduce the signals that raise blood pressure. For decades it was the go-to choice, and it still has the longest safety track record of any blood pressure medication in pregnancy. Infants exposed through breastfeeding receive less than 0.2% of the mother’s total daily dose.
That said, methyldopa has largely fallen to second-line status because it’s harder to tolerate than newer options. Drowsiness, fatigue, and dry mouth are common, and it can take longer to bring blood pressure under control. It remains widely used in developing countries because of its low cost, and your provider may still consider it if labetalol and nifedipine aren’t working well for you.
Medications That Are Not Safe During Pregnancy
If you were taking blood pressure medication before becoming pregnant, the type matters enormously. ACE inhibitors, angiotensin receptor blockers (ARBs), and direct renin inhibitors all interfere with a hormonal system that plays a critical role in fetal kidney development. Animal and human studies have conclusively shown these drugs cause fetal harm, particularly during the second and third trimesters. The damage can include severe kidney problems, low amniotic fluid, and skull defects. First-trimester exposure carries less certain but still concerning risk.
If you’re on any of these medications and are pregnant or planning to become pregnant, your provider will switch you to a pregnancy-safe alternative. This switch is one of the most important early steps in managing hypertension during pregnancy.
What Happens in a Hypertensive Emergency
When blood pressure spikes dangerously high during pregnancy, the situation requires fast-acting medication given in a hospital. Hydralazine was for many years the default emergency treatment, but a large review of clinical trials found it performed worse than alternatives in several important ways. Compared to labetalol and nifedipine, hydralazine was associated with more episodes of dangerously low blood pressure, more abnormal fetal heart rate patterns, more placental abruption (where the placenta separates from the uterine wall), and more cesarean sections. Its side effects, including headache, nausea, and rapid heartbeat, also overlap with symptoms of worsening preeclampsia, making it harder for your care team to tell what’s happening.
For these reasons, intravenous labetalol and oral nifedipine have increasingly replaced hydralazine as the preferred emergency options. All three are still used, but the trend in guidelines has shifted toward labetalol and nifedipine first.
Low-Dose Aspirin for Prevention
If you’re at high risk for preeclampsia, your provider may recommend a daily low-dose aspirin (81 mg) as a preventive measure. ACOG recommends starting it between 12 and 28 weeks of gestation, ideally before 16 weeks, and continuing until delivery. This isn’t a blood pressure medication in the traditional sense, but it reduces the risk of developing the dangerously high blood pressure and organ damage that define preeclampsia. Risk factors include a history of preeclampsia in a previous pregnancy, chronic hypertension, kidney disease, autoimmune conditions, and carrying multiples.
Monitoring Blood Pressure at Home
Home monitoring is an important part of managing blood pressure during pregnancy, but not all monitors are equally reliable for pregnant women. A systematic review published in the American Heart Association’s journal Hypertension found that of 28 devices tested, only a handful passed validation specifically in pregnant populations. For home use, the Microlife WatchBP Home and Omron MIT were validated in both normotensive and hypertensive pregnant women without preeclampsia. The Omron MIT Elite passed for both home and clinic use.
Many standard consumer monitors have never been tested in pregnant women, and pregnancy-related changes in blood flow can affect accuracy. If you’re tracking your numbers at home, it’s worth confirming that your device has been validated for pregnancy. Your provider can help you determine how often to check and what readings should prompt a call.
After Delivery: What Changes
Blood pressure management doesn’t end with delivery. Some women develop high blood pressure for the first time in the days after giving birth, and those who had gestational hypertension or preeclampsia often need continued medication. The good news is that the medication options expand after pregnancy. If you’re breastfeeding, labetalol, nifedipine, and methyldopa all transfer into breast milk at very low levels. Several other classes also appear safe for nursing: studies show that enalapril transfers at about 0.16% of the maternal dose, metoprolol at 0.005% to 0.01%, and amlodipine at levels so low they’re undetectable in infant blood.
Your provider may keep you on your pregnancy medication or switch you to something that better fits your long-term needs now that the fetal safety constraints are lifted. Women who had preeclampsia carry a higher lifetime risk of heart disease and chronic hypertension, so ongoing blood pressure monitoring remains important well beyond the postpartum period.